Christophe Reymond

Keine laufenden Positionen mehr

Consumer Services

Health Technology

Profil

Dr. Christophe Reymond is Chief Scientific Officer at Anergis SA. Dr. Reymond was previously employed as an Assistant Professor by University of Lausanne, Chief Scientific Officer by Dictagene, and Researcher by University of California San Diego.

Ehemalige bekannte Positionen von Christophe Reymond

Unternehmen	Position	Ende
Dictagene	Gründer	01.01.2005
University of Lausanne	Corporate Officer/Principal	01.01.2001
University of California San Diego	Corporate Officer/Principal	-
Anergis SA Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland.	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Christophe Reymond im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Christophe Reymond im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Anergis SA Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland.	Health Technology
Dictagene